Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001568605-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-05 | SANA | Wyrick Susan D. | See Remarks | F - Tax | $4.27 | -2,407 | 185.9K | -1% | -$10.3K |
| D | 2026-01-06 | 2026-01-02 | SANA | Wyrick Susan D. | See Remarks | M - OptEx | $0.00 | +7,500 | 188.3K | +4% | $0 |
| D | 2026-01-06 | 2026-01-02 | SANA | Wyrick Susan D. | See Remarks | M - OptEx | — | -7,500 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | F | D | 2,407 | $4.27 | 185,883 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-02 | M | A | 7,500 | $0.00 | 188,290 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-02 | M | D | 7,500 | — | 0 | D | — · — to — | 7,500 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock. (F2) The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026. |